Financial information

The information source is the annual report of the company with business id 556138-6532

* Closing information (×1000) SEK

Fiscal year 202412 202312 (consolidated)
Number of months: 12 12
Turnover: 25,380,000 Revenue Up 23,270,000 Revenue Up
Financial expenses: 24,000 Revenue Down 302,000 Revenue Up
Earnings before taxes: 926,000 Revenue Up 819,000 Revenue Up
Total assets: 15,164,000 Revenue Up 13,398,000 Revenue Up
Current assets: 6,458,000 Revenue Up 5,825,000 Revenue Up
Current liabilities: 3,012,000 Revenue Up 2,883,000 Revenue Up
Equity capital: 9,922,000 Revenue Up 8,500,000 Revenue Up
Share capital: 175,000 175,000
Number of employees: 3,025 Revenue Up 2,885 Revenue Up

Financial ratios

Solvency: 65.4% Revenue Up 63.4% Revenue Up
Turnover per employee: 8,390 Revenue Up 8,066 Revenue Up
Profitability: 3.6% Revenue Up 3.5% Revenue Up
Return on equity (ROE): 9.3% Revenue Down 9.6% Revenue Up
Current ratio: 214.4% Revenue Up 202.0% Revenue Up
Return on assets (ROA): 6.3% Revenue Down 8.4% Revenue Up

Companies with similar products and services, and with detailed information

  • Solveco AB

    Pharmaceuticals. Medicinal chemicals. Botanical produc...

Fiscal year 202412
Number of months: 12
Turnover: 25,380,000
Financial expenses: 24,000
Earnings before taxes: 926,000
Total assets: 15,164,000
Current assets: 6,458,000
Current liabilities: 3,012,000
Equity capital: 9,922,000
Share capital: 175,000
Number of employees: 3,025

Financial ratios

Solvency: 65.4%
Turnover per employee: 8,390
Profitability: 3.6%
Return on equity (ROE): 9.3%
Current ratio: 214.4%
Return on assets (ROA): 6.3%